Abbey Pharmaceuticals Limited 06758034 false true 2013-05-01 2014-04-30 2014-04-30 06758034 2013-05-01 2014-04-30 06758034 2014-04-30 06758034 uk-bus:OrdinaryShareClass1 2014-04-30 06758034 uk-bus:Director2 2013-05-01 2014-04-30 06758034 uk-bus:OrdinaryShareClass1 2013-05-01 2014-04-30 06758034 2013-04-30 06758034 2013-04-30 06758034 uk-bus:OrdinaryShareClass1 2013-04-30 iso4217:GBP xbrli:shares

Registration number: 06758034

Abbey Pharmaceuticals Limited

Unaudited Abbreviated Accounts

for the Year Ended 30 April 2014
 

 

Abbey Pharmaceuticals Limited
Contents

Abbreviated Balance Sheet

1

Notes to the Abbreviated Accounts

2

 

Abbey Pharmaceuticals Limited
(Registration number: 06758034)
Abbreviated Balance Sheet at 30 April 2014

   

Note

    

2014
£

    

2013
£

  

Current assets

  

             

Debtors

  

   

1,000

   

1,000

 

Capital and reserves

  

             

Called up share capital

 

2

   

1,000

   

1,000

 

Shareholders' funds

  

   

1,000

   

1,000

 

For the year ending 30 April 2014 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime .

Approved by the Board on 15 October 2014 and signed on its behalf by:

.........................................
Mr Kevin James
Director

The notes on page 2 form an integral part of these financial statements.
Page 1

 

Abbey Pharmaceuticals Limited
Notes to the Abbreviated Accounts for the Year Ended 30 April 2014
......... continued

1

Accounting policies

Basis of preparation

The full financial statements, from which these abbreviated accounts have been extracted, have been prepared under the historical cost convention and in accordance with the Financial Reporting Standard for Smaller Entities (Effective April 2008).

Financial instruments

Financial instruments are classified and accounted for, according to the substance of the contractual arrangement, as financial assets, financial liabilities or equity instruments. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities. Where shares are issued, any component that creates a financial liability of the company is presented as a liability in the balance sheet. The corresponding dividends relating to the liability component are charged as interest expense in the profit and loss account.

2

Share capital

Allotted, called up and fully paid shares

 

2014

2013

   

No.

   

£

   

No.

   

£

 

Ordinary of £1 each

 

1,000

   

1,000

   

1,000

   

1,000

 
                         

3

Control

The company is controlled by Abbey Pharma Limited A company incorporated in England and owning 100% of the issued share capital of the company. The ultimate controlling party is Mr K James and Mr S Choudhary.

Page 2